Adviser

Download Secondaries Investor’s Global Market Survey

Secondaries Investor’s inaugural survey of LPs, secondaries buyers, GPs and advisers offers a complete view of the market and the direction it’s heading in. Conducted in partnership with Goodwin.

Palico reduces fees to 5bps for $50m-plus sales

The digital LP-led secondaries marketplace, which has facilitated smaller transactions since its founding, is seeking to attract larger sales, founder and CEO Antoine Dréan told Secondaries Investor.

Evercore builds out Europe-based credit secondaries team

The investment bank has hired four people, two of whom are coming from PJT, Secondaries Investor understands.

Technology moves down the list of favoured CV sectors – Houlihan Lokey

The investment bank is seeing a boost in interest in other sectors as the secondaries market reacts to tech disruption, managing director Michael Pilson told Secondaries Investor.

Goldman Sachs hires PJT managing director Darren Schluter

The investment bank had hired Rothschild’s London-based head of GP Solutions late last year.

Edmond de Rothschild Corporate Finance and Jasmin Capital form partnership for CVs

The investment bank and placement agent will together focus on co-control deals where GPs are seeking to sell part of a stake via M&A and move the remainder into a CV.

Evercore APAC secondaries director departs

The investment bank recently hired ex-Adams Street Partners Asia investor relations head Ben Hart to lead its APAC private capital advisory business.

2026 should set another record despite macro uncertainty: PJT’s Millan

The secondaries market is taking stock of macro events, which could lead to some movements around pricing, PJT Partners’ Adrian Millan said at NEXUS 2026.

LPs are not waiting on the promise of distributions: William Blair’s Stuiver

An eventual uptick in distributions will lead to higher pricing, which will see a larger proportion of opportunistic LPs coming to the market, managing director Jake Stuiver tells Secondaries Investor.

CVs now established as exit route alongside M&A and IPO: Moelis’s Hammer

Secondaries buyers’ own specialisation is aiding in GPs’ interest to consider a CV in tandem with other exit options, Moelis & Co managing director Jeff Hammer said at NEXUS 2026.